About Formycon
Formycon is a leading and independent developer of high-quality biopharmaceutical follow-on products (biosimilars) for global commercialization. The company covers the entire value chain of biosimilar development from analytics to clinical phase III and regulatory approval.
Formycon develops biosimilars in particular for approval in highly regulated markets (EU, USA, Japan, Canada, Australia) and positions itself as a preferred partner for large pharmaceutical and generics companies.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Biotechnology
